#USA #Madison Heights #Clinical Advisory Board #Mopec #Pathology Solutions

Mopec Announces the Launch of Its First Clinical Advisory Board to Enhance Pathology Solutions

Introducing Mopec's Clinical Advisory Board

On September 30, 2025, Mopec, a prominent company in anatomic and forensic pathology solutions, unveiled its first-ever Clinical Advisory Board. This momentous initiative is aimed at ensuring that the needs and voices of pathology professionals are at the core of Mopec's innovation strategies.

The Clinical Advisory Board, formed in late 2024, includes a diverse team of expert pathologists, histotechnologists, and pathologists’ assistants with varied backgrounds in relevant fields such as academic medicine, pediatric pathology, informatics, and translational research. The group shares a common goal: to enhance the field of pathology by developing practical, customer-focused solutions that cater to professionals operating on the frontlines.

Francis X. Dirksmeier, CEO of Mopec Group, stated, "Our mission is both straightforward and ambitious. We aim for every Mopec product, service, and initiative to be influenced by the voices of those who utilize them on a daily basis. The establishment of this Clinical Advisory Board underscores our commitment to truly listen, learn, and continually improve the treatment of diseases."

The introduction of the Clinical Advisory Board seeks to achieve two main objectives:
1. To create a structured platform that will facilitate direct feedback concerning industry trends, challenges, and emerging requirements.
2. To synchronize Mopec's product development roadmap with real-world workflows, clinical obstacles, and the evolving standards of care.

The Advisory Board convenes quarterly, with each meeting designed to yield actionable insights and feedback that directly informs Mopec's approach to various aspects including equipment design, technology integration, training methods, and workflow optimization. Discussion on the board is characterized by an emphasis on real-world contributions, rather than being reduced to theoretical dialogues alone. "This board is a catalyst for progress and not merely a think tank in name," asserted Alexandria Gonzales, Director of Technology and Innovation at Mopec Group.

What distinguishes the Clinical Advisory Board is its encouragement of cross-disciplinary dialogues. This inclusive approach helps to ensure that a wide variety of perspectives is taken into account:

- Autopsy specialists contribute to the development of products that meet the unique needs of postmortem examinations.
- Histotechnologists identify areas where technology can enhance specimen management and laboratory efficiency.
- Pathologists’ assistants advocate for tools that ensure standardization, safety, and efficiency in tissue handling processes.
- Pathologists provide critical insights that improve traceability, diagnostic precision, and the efficacy of digital documentation.

This collaborative method allows Mopec to gather insights that tackle the day-to-day realities faced by pathology professionals, ensuring solutions that not only meet industry standards but also respond to practical concerns.

The inaugural meeting of the Clinical Advisory Board took place in June 2025, marking a significant step in converting this vision into tangible results. Members had the opportunity to tour Mopec’s facility, witness live product demonstrations, and participate in structured discussions that helped outline clear actionable priorities moving forward. The enthusiasm generated from these exchanges highlighted the potential and significance of this initiative.

Roseann Vitale, Product Manager and Co-Chair of the Advisory Board, expressed excitement about the future, stating, "We are merely at the beginning of this journey. We are looking forward to what lies ahead. With the guidance of this board, our aim is not just to produce superior products—we aspire to develop solutions that will genuinely benefit the professionals who depend on them every day."

In an evolving and growing landscape, the Clinical Advisory Board is set to remain a fundamental aspect of Mopec's ongoing strategy, helping the company remain connected to the needs of practitioners while continuously pushing the limits of what can be achieved in the field of pathology.

About Mopec

Mopec Group is based in Madison Heights, Michigan, and specializes in providing high-quality equipment, technology, and services for anatomic and forensic pathology. Founded in 1992, Mopec has built a reputation for its commitment to innovation and engineering excellence, continually striving to elevate the standards of pathology across laboratories within hospitals, universities, morgues, and beyond. For more details, visit Mopec Group and Mopec.